Sanofi Files Consent Solicitation To Remove and Replace Medivation's Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Medivation (MDVN) Urges Holders to Reject Sanofi's Attempt to Replace Board
May 25, 2016 8:49 AM EDTMedivation, Inc. (NASDAQ: MDVN) today urged its stockholders to reject Sanofis attempt to replace the companys entire Board of Directors with hand-picked nominees through a proposed consent solicitation, which Medivation believes is a tactic for Sanofi to facilitate its substantially inadequate and opportunistically-timed proposal to acquire Medivation. Medivation expects to promptly file consent revocation materials with the U.S. Securities and Exchange Commission.
On April 29, 2016, the Medivation Board unanimously rejected Sanofis unsolicited, non-binding proposal to purchase Medivation for $52.50 per share in cash because it substantially undervalues the... More
